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ABSTRACT
Misdiagnosis and delayed treatment of Mycobacterium 
marinum infection is common because of its diverse 
manifestations. This leads to inappropriate use of 
antimicrobials, extension of the infection from the 
skin to the tenosynovium, and a poor prognosis 
(loss of tendons and prolonged immobilisation, 
secondary to multiple debridements and joint 
contractures). Clinicians should be aware of this type 
of infection, especially in subjects at risk (fishermen 
and aquarium enthusiasts), and those with a history 
of trauma coupled with exposure to water or marine 
life. A proactive approach to obtain a biopsy for 
histopathological and microbiological diagnosis is 
advised. Anti-mycobacterial treatment should be 
started promptly. The combined use of rifampicin, 
ethambutol, and clarithromycin appears to be 
effective, and debridement is indicated in patients 
with deep-seated infections.
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INTRODUCTION
Mycobacterium marinum was first discovered in salt-
water fish in 1926, but was not identified in humans 
until 1951.1 Its manifestations vary from a single skin 
granuloma to sporotrichoid nodules and tenosynovitis 
of the hand, which are often misdiagnosed and 
treatment is commonly delayed. This mycobacterium 
is free-living and found worldwide in both freshwater 
and marine environments. Infection can be caused by 
direct injury from fish fins or fish bites or during the 
handling of fish tanks. Local trauma is an important 
factor predisposing to infection. We review the 
diagnosis and management of M marinum infection 
in the literature.
METHODS
Databases of Medline, PubMed, and the Cochrane 
library were searched using the key words 
‘Mycobacterium marinum’ and ‘tenosynovitis’. 
Articles published in English involving M marinum 
infection of the hand and wrists were included. 
Epidemiology, microbiology, diagnostic difficulties, 
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clinical presentations, culture findings, histology, 
treatment, and long-term outcomes (such as loss of 
hand function) were reviewed. References in review 
articles were screened for potentially relevant studies 
not yet identified.
EPIDEMIOLOGY
Among infections of the hand, M marinum accounts for 
0.04 to 0.27 per 100 000 cases.2 Most patients are aged 
38 to 45 years2–5 and are infected from water or other 
environmental sources through superficial abrasions. 
In a Singaporean study of 38 patients, 34% kept fish at 
home, 11% had fish-related occupations, and 32% had 
a history of trauma.3 In a French study of 63 patients, 
84% had exposure to fish tanks.6 In a Hong Kong 
report on 24 patients, 67% were fishermen, and 67% 
had sustained a puncture wound prior to seawater 
contact.4
MICROBIOLOGY
M marinum is a natural pathogen of ectotherms such 
as frogs and fish. It has an extensive habitat and can 
live saprophytically in a warm aquatic environment.7 
It grows on Lowenstein-Jensen medium, forming 
moist, compact colonies that become evident after 
2 to 3 weeks of culture. It is optimally cultured at a 
temperature of 25ºC to 35ºC, and therefore infection 
usually occurs in cooler parts of the body (such 
as extremities)8; 74% to 95% develop in the upper 
extremities, 36% to 59% being in the fingers.3,6,9
CLINICAL MANIFESTATIONS
There are no pathognomonic features of M marinum 
infection, and the presenting symptoms are diverse. 
Skin lesions may be single or multiple and initially 
may appear papulonodular. Common misdiagnoses 
include cellulitis or abscess, fungal and parasitic 
infection, tuberculosis verrucosa cutis, gout, 
rheumatoid arthritis, trigger finger, foreign body 
reaction, and skin tumour.1,2
 20% to 33% of patients present with a 
sporotrichoid pattern—the spread of nodular or 
ulcerating skin lesions proximally along the line of 
lymphatic drainage to the regional lymph nodes.2,9 
This manifestation tends to persist and does not heal 
spontaneously.
 M marinum infection is categorised into 3 types. 
Type I forms self-limiting verrucal lesions, type II 
forms single or multiple subcutaneous granulomas 
with or without ulceration, and type III results in 
deep infections involving the tenosynovium, bursa, 
bones or joints causing tenosynovitis, septic arthritis 
or osteomyelitis.1 Deep infections of the latter 
type usually results from extension of cutaneous 
infections or direct inoculation, rather than through 
haematogenous spread.10
 In a Singaporean study, 66% of patients presented 
with plaques, 26% with nodules, 5% with papules, 
and 3% with an ulcer.3 In a French study, 67% of 
patients presented with nodules, of which 39% 
had a sporotrichoid pattern.6 In an American study 
of 15 patients, 29% presented with one or more 
subcutaneous masses, and 57% had tenosynovitis.5 
 The presenting symptoms vary and include 
painful swelling associated with stiffness and 
numbness,5 local pain,9 swelling and limitation of 
motion and discharging sinuses.4 In rare instances, 
patients present with a disseminated disease such 
as multiple cutaneous lesions on both sides of the 
upper and/or lower limbs, and even in the lungs and 
abdominal organs. Disseminated infections usually 
occur in immunocompromised patients including 
those taking steroids.11,12
 Delay in presentation and delay in making a 
definitive diagnosis is common. In one series the 
mean delay from injury to presentation was 32 days.2 
In another, the median time from inoculation to 
appearance of a lesions was 16 (range, 0–292) days.6 
Owing to the indolent nature of early lesions, patients 
often do not seek medical attention until symptoms 
become more florid. Others reported the mean delay 
from the onset of symptoms to consultation to be 
7.7 (range, 1–36) months,5 and the mean delay from 
the onset of symptoms to a definitive diagnosis 
was 3.5 months, the longest delay being 8 months.4 
Furthermore, the initial diagnosis was usually 
erroneous.
DIAGNOSIS
Initial clinical and radiological findings are often 
non-specific. Plain radiography may show soft-
tissue swelling only5 and does not differentiate the 
disease from other granulomatous or mycobacterial 
infections. Magnetic resonance imaging may show 
exuberant tenosynovitis, fluid collection around 
tendons, and bone erosions, which are all features of 
type-III infection.13
 A definitive diagnosis is based on a positive 
culture of M marinum. The mean time taken to detect 
its growth in culture was 25 days and the mean 
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time to bacterial identification and availability of 
antimicrobial susceptibility was another 26 days.9 
Therefore, the mean time from biopsy to positive 
bacterial profile and antimicrobial susceptibility 
results was 2.3 months.9 Thus, treatment is always 
delayed, and the mean time to surgery has been 
reported as 63 (range, 33–122) days.2 Depending on 
the series, only 3%3 to 55%14 of M marinum infections 
yield positive cultures.
 Diffuse and focal granulomatous inflammation 
affects the tendon sheath, fibroadipose tissue and 
skeletal muscle.4,15 The normal intimal lining of 
synovial cells and sub-intimal supportive fibrofatty 
tissues are replaced and thickened by masses of 
inflammatory infiltrate combined with granulation 
tissue. There is extensive ulceration with destruction 
of the synovial structure (Fig. 1). The residual synovial 
lining cells appear hypertrophic but show minimal 
hyperplasia. Biopsied tissues show scattered small, 
well-formed, epithelioid, non-caseating granulomata 
with Langhans giant cells.16,17 Poorly formed 
granulomatous reactions with caseating necrosis 
are also seen.16,17 Long, slender and beaded acid-fast 
bacilli are seen in fibrinous exudates or among caseous 
material (Fig. 2). In deeper tissue sections, focal 
necrotising granulomas and diffuse granulomatous 
inflammation can be seen extending between the 
fibres of adjacent skeletal muscles.18,19 Osteomyelitis 
may be seen with granulomatous inflammation, 
and the dead bone or sequestrum is surrounded by 
granulation tissue and chronic inflammatory cells. 
There is no evidence of new bone formation.16
 Only 46% of patients present with typical 
pathological findings.6 Granulomata are present 
in 38% of patients, and acid-fast bacilli have been 
identified (using Ziehl-Neelsen stains) in 17%9 and 
13%3 of patients. The mean duration of skin lesions 
is longer in those with granulomata than in those 
without (7.9 vs. 4.7 months).9 
 The diagnosis of M marinum is often delayed, 
primarily owing to the lack of clinical suspicion 
and failure to elicit a history of aquatic exposure. 
Clinicians should review the patient’s occupational 
and recreational activities, including any history of 
penetrating injury or regular exposure to seawater 
or fresh water. Many patients are inoculated through 
superficial abrasions, which may lead to deep-
seated infections rather than granulomata. Common 
misdiagnoses include sporotrichosis, mycobacterial 
infections, gout, rheumatoid arthritis, foreign body 
reactions, and even tumours (such as epithelioid 
sarcomas). 
ANTIMICROBIAL TREATMENT
Antimicrobial agents and duration of treatment vary 
Figure 1 Extensive tenosynovitis and synovectomy
Figure 2 Mycobacterium marinum under Ziehl-Neelsen 
stain (x1000)
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considerably (Table 1).2–6,9,14,20–22 The optimal regimen 
has not been established and the choice of regimen is 
mainly based on the treating surgeon’s preference. All 
drug regimens have resulted in failure and success. 
M marinum is almost always resistant to isoniazid 
and frequently also to streptomycin. It is susceptible 
in vitro to: rifampicin, ethambutol, clarithromycin, 
cotrimoxazole, some tetracyclines (doxycycline and 
minocycline) and certain newer quinolones (such 
as ciprofloxacin, levofloxacin, and moxifloxacin). 
For superficial infections of the skin, monotherapy 
with cotrimoxazole or tetracycline is sufficient. For 
deep-seated infections, combination therapy with or 
without surgical debridement is recommended. 
 In a French study, the median duration of 
antibiotic therapy was 3.5 (range, 1–25) months.6 The 
regimen was significantly longer for deep infections 
than skin and soft-tissue infections (median, 7.5 vs 4 
months, p=0.004).6 At least 3 months of treatment is 
recommended, and sometimes up to 6 months, and 
at least 2 more months after the lesions have subsided 
(Table 2). 37% of patients underwent monotherapy 
(with minocycline, doxycycline, or clarithromycin), 
whereas 63% received a combination of at least 2 
drugs (clarithromycin and rifampicin, minocycline 
or doxycycline and clarithromycin, rifampicin and 
ethambutol, and minocycline or doxycycline and 
rifampicin).6 In all, 87% of the patients were cured.6 
Failure was related to the spread of infection to deeper 
structures and the skin lesion aspect of the ulcer, 
and not to the prescription of any specific antibiotic 
regimen or the duration of treatment.6
 As rifampicin has excellent bone-penetrating 
ability, the American Thoracic Society and 
Infectious Disease Society of America recommend 
clarithromycin and ethambutol for most patients, with 
addition of rifampicin in patients with osteomyelitis 
or other deep infections.23 
 In our hospital, most patients were treated with 
rifampicin and ethambutol. In patients with no 
history of exposure or tuberculous involvement, 
empirical anti-tuberculous treatment with isoniazid, 
pyrazinamide, rifampicin, and ethambutol was used. 
This regimen confers adequate cover against both 
tuberculosis and M marinum infection. Clarithromycin 
and/or levofloxacin may be added in some patients 
when other atypical mycobacterial infections are 
suspected, when the patient is intolerant or allergic 
to other first-line drugs, or when there is extensive 
disease.
SURGICAL TREATMENT
Excision or debridement is necessary in patients 
with type-III infections refractory to antibiotics.6 The 
Study Year Region No. of 
cases
Recommended antibiotic regimen Duration 
(months)
Outcome
Donta et al.20 1986 USA 2 Tetracycline & cotrimoxazole or rifampicin & 
ethambutol
3–6 All responded
Hurst et al.5 1987 USA 15 Tetracycline or minocycline 2–6 87% healed
Chow et al.4 1987 Hong 
Kong
24 Rifampicin & ethambutol 9 58% responded
Ljungberg et al.21 1987 Sweden 2 Tetracycline or ethambutol or cotrimoxazole 9 All resolved
Laing et al.22 1997 UK 3 Clarithromycin & ciprofloxacin 5 All responded
Ang et al.3 2000 Singapore 38 Minocycline or doxycycline or cotrimoxazole 
or rifampicin & ethambutol
3–6 69% improved
Aubry et al.6 2002 France 63 Clarithromycin or minocycline or doxycycline 
or rifampicin & ethambutol
3.5 87% cured
Ho et al.14 2006 Hong 
Kong
17 Tetracycline &/or minocycline 4.9 94% treated
Pang et al.2 2007 Singapore 5 Cotrimoxazole or doxycycline or xlarithromycin 3.9 80% treated
Dodiuk-Gad et al.9 2007 Israel 25 Clarithromycin 3 All healed
Table 1
Antibiotic regimens
Condition Treatment protocol
Standard regimen for 
previously untreated 
patient
Ethambutol and rifampicin or 
minocycline and rifampicin
Relapse after treatment Clarithromycin and 
minocycline and ethambutol
Duration of treatment 6 months total or at least 2 
more months after definite 
clinical improvement
Table 2
Recommended treatment protocol
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excised tenosynovium is similar to giant cell tumours 
of the tendon sheath but less encapsulated and more 
adherent to surrounding structures.5 Grossly the 
synovium appears thickened and varies from being 
oedematous to firm. Fibrin covers some of the synovial 
surfaces and the colour varies from light grey to beefy 
red to brown.18 The mean number of debridements to 
achieve clearance was 3.4 (range, 2–4).2
REHABILITATION
Debridement and synovectomy may lead to extensive 
scarring, joint contracture, and loss of function. In 
5 patients undergoing extensive synovectomy, the 
mean postoperative total active motion of the finger 
was only 94º (range, 55º–190º).2 Although early 
mobilisation could improve hand function, it violates 
the principle of resting infected parts and might 
lead to a flare-up, wound dehiscence, and persistent 
sinus formation. As a compromise, immobilisation 
of the hand has been suggested for 7 to 10 days, by 
which time the wound is more stable for vigorous 
exercise,15 and 88% of the patients achieved a range 
of motion similar to that of the unaffected hand.4 
The remaining patients underwent excision of the 
flexor tendons to control the infection or developed 
multiple joint contractures after 3 debridements.4 In 
83% of the patients, hand grip power was ≥90% of 
that of the normal hand.4 None of the patients had 
problems with performing activities of daily living or 
pursuing their original occupation.4 We recommend 
immobilisation of the hand for 10 to 14 days before 
carrying out mobilisation exercises.
PROGNOSIS
Risk factors for a poor prognosis after M marinum 
infection include an underlying immunocompromised 
condition secondary to disease or immunosuppressive 
agents. The use of systemic steroids may interfere 
with normal monocyte-macrophage functions.12 
An antibiotic regimen of 9 to 12 months may be 
needed.12
 The infection is exacerbated when it is 
misdiagnosed as gout, rheumatoid arthritis or lupus 
and treated with steroid injections.11 54% of patients 
with M marinum infection received local injections of 
steroids before admission.4 In 85% of such patients, 
there was delayed wound healing or poor response 
to medications and recourse to subsequent surgical 
debridement.4 Persistent pain and discharging sinuses 
are also poor prognostic factors.4 90% of patients 
who underwent surgical debridement experienced 
persistent pain, whereas only 7% did so when treated 
conservatively.4 Likewise, 50% of patients having 
surgical debridement had a discharging sinus in 
contrast to 14% who were treated conservatively.4 
These findings suggest that injection of steroids, 
persistent pain, and discharging sinuses are associated 
with a poor prognosis.
 The main prognostic indicator in M marinum 
infections is the promptness of treatment. Delayed 
or inappropriate treatment can lead to the loss of 
hand function. For instance, intra-lesional injections 
of corticosteroids exacerbate the infection. Thus, 
clinical awareness for this infection must be stressed, 
especially in patients with occupational risks and 
seawater exposure.
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